Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Strategic Diagnostics has announced that it will be providing Jason Lieb's Laboratory at University of North Carolina, Chapel Hill with a library of antibodies produced through its Genomic Antibody Technology platform.
Subscribe to our email newsletter
Mr Lieb has selected these antibodies for use in his work that is part of the National Human Genome Research Institute’s model-organism Encode (modENCODE) project. The project is working to identify and characterize DNA sequence elements and proteins that control genome activity in the Caenorhabditis elegans (worm) and Drosophila melanogaster (fruit fly) genomes.
The project, sponsored by the National Institutes of Health, will focus specifically on those areas of the genome that regulate chromosomal functions such as transcription, DNA replication and repair, recombination and chromosome segregation. The project is dependent upon quality antibodies to profile the protein dynamics in the study systems.
In the arrangement, Strategic Diagnostics (SDI) will retain the commercial rights to the antibodies produced and will be the sole commercial distributor to the scientific community through its SEQer catalog.
Matthew Knight, president and CEO of SDI, said: “We are very pleased to have been selected to generate this library to further the understanding of chromosome function on the protein level. The Lieb group selected SDI and Genomic Antibody Technology due to the clear financial benefit of our technology and success rates beyond traditional methods.”